Renal Survival and Validation of Novel International Immunoglobulin a Nephropathy Prediction Tool in Latvian Population: Preliminary Data
By:
References
- Barbour, S. J., Coppo, R., Zhang, H., Liu, Z. H., Suzuki, Y., Matsuzaki, K., Katafuchi, R., Er, L., Espino-Hernandez, G., Kim, S. J., Reich, H. N., Feehally, J., Cattran, D. C. (2019). International IgA nephropathy network. Evaluating a new International Risk-Prediction Tool in IgA Nephropathy. JAMA Intern Med., 179 (7), 942–952. Erratum in: JAMA Intern Med., 2019, 179 (7), 1007.
- Barbour, S. J., Espino-Hernandez, G., Reich, H. N., Coppo, R., Roberts, I. S., Feehally, J., Herzenberg, A. M., Cattran, D. C. (2016). The MEST score provides earlier risk prediction in lgA nephropathy. Kidney Int., 89 (1),167–175.10.1038/ki.2015.32226759049
- Chang, A., Laszik, Z. (2018). Kidney and its collecting system. In: Vinay, K., Abbas, A. K., Aster, J. C. (eds.). Robbins Basic Pathology. Elsevier, Philadelphia, Chapter 14, pp. 549–581.
- Chen, D., Liu, J., Duan, S., Chen, P., Tang, L., Zhang, L., Feng, Z., Cai, G., Wu, J., Chen, X. (2018). Clinicopathological features to predict Pprogression of IgA nephropathy with mild proteinuria. Kidney Blood Press Res., 43 (2), 318–328.10.1159/00048790129529608
- Cheng, J., Zhang, W., Zhang, X. H., He, Q., Tao, X. J., Chen, J. H. (2009). ACEI/ARB therapy for IgA nephropathy: A meta-analysis of randomised controlled trials. Int. J. Clin. Pract., 63 (6), 880–888.10.1111/j.1742-1241.2009.02038.x19490198
- Cheng, Y. S., Barratt, J. (2018). Immunoglobulin A nephropathy and related disorders. In: Gilbert, S., Weiner, D. E. National Kidney Foundation Primer on Kidney Diseases. Elsevier, Edinburgh. 680 pp.
- Cheung, C. K., Barratt, J. (2020). IgA nephropathy: Pathogenesis. https://www.uptodate.com/contents/iga-nephropathy-pathogenesis (accessed 15.09.2021).
- Coppo, R., D’Arrigo, G., Tripepi, G., Russo, M. L., Roberts, I. S. D., Bellur, S., Cattran, D., Cook, T. H., Feehally, J., Tesar, V., et al. (2020). Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update. Nephrol. Dial. Transplant., 35 (6), 1002–1009.10.1093/ndt/gfy30230418652
- Duan, Z. Y., Cai, G. Y., Chen, Y. Z., Liang, S., Liu, S. W., Wu, J., Qiu, Q., Lin, S. P., Zhang, X. G., Chen, X. M. (2013). Aging promotes progression of IgA nephropathy: A systematic review and meta-analysis. Amer. J. Nephrol., 38 (3), 241–252.10.1159/00035464624021632
- Geddes, C. C., Rauta, V., Gronhagen-Riska, C., Bartosik, L. P., Jardine, A. G., Ibels, L. S., Pei, Y., Cattran, D. C. (2003). A tricontinental view of IgA nephropathy. Nephrol. Dial. Transplant., 18 (8), 1541–1548.10.1093/ndt/gfg20712897092
- eGFR using CKD-EPI. https://qxmd.com/calculate/calculator_251/egfr-using-ckd-epi (accessed 15.09.2021).
- Hennino, M., Buob, D., van der, Hauwaert, C., Gnemmi, V., Jomaa, Z., Pottier, N., Savary, G., Drumez, E., Noël, C., Cauffiez, C., Glowacki, F. (2016). miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy. Sci. Rep., 6, 27209 (2016).
- Kiryluk, K., Li, Y., Sanna-Cherchi, S., Rohanizadegan, M., Suzuki, H., Eitner, F., Snyder, H. J., Choi, M., Hou, P., Scolari, F., et al. (2012). Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Gen., 8 (6), e1002765.10.1371/journal.pgen.1002765338084022737082
- Krūmiņa, A., Pliss, L., Zariņa, G., Puzuka, A., Zariņa, A., Lāce, B., Elferts, D., Khrunin, A., Limborska, S., Kloviņš, J., Gailīte Piekuse, L. (2018). Population genetics of Latvians in the context of admixture between North-Eastern European ethnic groups. Proc. Latvian Acad. Sci., Section B, 72 (3), 131–151.10.2478/prolas-2018-0025
- Lai, K., Tang, S., Schena, F., Novak, J., Tomino, Y., Fogo, A. B., Glassock, R. J. (2016). IgA nephropathy. Nat. Rev. Dis. Primers, 2, 16001.10.1038/nrdp.2016.127189177
- McGrogan, A., Franssen, C. F. M., Vries, C. S. (2011). The incidence of primary glomerulonephritis worldwide: A systematic review of the literature. Nephrol. Dial. Transplant., 26 (2), 414–430.10.1093/ndt/gfq66521068142
- Moriyama, T., Tanaka, K., Iwasaki, C., Oshima, Y., Ochi, A., Kataoka, H., Itabashi, M., Takei, T., Uchida, K., Nitta, K. (2014). Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS One, 9 (3), e91756.10.1371/journal.pone.0091756396237324658533
- Nagy, J., Kovács, T., Wittmann, I. (2005). Renal protection in IgA nephropathy requires strict blood pressure control. Nephrol. Dial. Transplant., 20 (8), 1533–1539.10.1093/ndt/gfh92015956069
- New International IgAN Prediction Tool. https://qxmd.com/calculate/calculator_499/international-igan-prediction-tool (accessed 13.10.2021).
- Rauen, T., Fitzner, C., Eitner, F., Sommerer, C., Zeier, M., Otte, B., Panzer, U., Peters, H., Benck, U., Mertens, P. R. et al. (2018). Effects of two immunosuppressive treatment protocols for IgA nephropathy. J. Amer. Soc. Nephrol.,, 29 (1) 317–325.10.1681/ASN.2017060713574892529042456
- Roberts, I. S.D. (2019). Kidney diseases. In: Cross, S. S. (Ed.). Underwood’s Pathology: A Clinical Approach. Elsevier, Edinburgh, pp. 494–522.
- Rodrigues, J. C., Haas, M., Reich, H. N. (2017). IgA Nephropathy. Clin. J. Amer. Soc. Nephrol., 12 (4), 677–686.10.2215/CJN.07420716538338628159829
- Schena, F. P., Nistor, I. (2018). Epidemiology of IgA nephropathy: A global perspective. Seminars in Nephrology, 38 (5), 435–442.10.1016/j.semnephrol.2018.05.01330177015
- Schimpf, J. I., Klein, T., Fitzner, C., Eitner, F., Porubsky, S., Hilgers, R. D., Floege, J., Groene, H. J., Rauen, T. (2018). Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores). BMC Nephrol., 19 (1), 328.10.1186/s12882-018-1128-6624578130453889
- Silbiger, S. R. (2011). Raging hormones: Gender and renal disease. Kidney Int., 79 (4), 382–384.10.1038/ki.2010.47421278778
- Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y., Castro, III, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., van Lente, F., Greene, T., Coresh, J. (2009). A new equation to estimate glomerular filtration rate. Ann. Intern. Med., 150, 604–612.10.7326/0003-4819-150-9-200905050-00006276356419414839
- The International IgA NEPHROPATHY (IgAN). Prediction Tool Information for nephrologists and other healthcare professionals. https://ukkidney.org/sites/renal.org/files/2-IgAN-Risk-Prediction-Tool-info-for-Health-Professionals.pdf (accessed 15.09.2021).
- Zhang, J., Huang, B., Liu, Z., Wang, X., Xie, M., Guo, R., Wang, Y., Yu, D., Wang, P., Zhu, Y., Ren, J. (2020). External validation of the International IgA Nephropathy Prediction Tool. Clin. J. Amer. Soc. Nephrol., 15 (8) 1112–1120.10.2215/CJN.16021219740975332616496
Language: English
Page range: 379 - 386
Submitted on: Dec 29, 2020
Accepted on: Mar 27, 2021
Published on: Nov 15, 2021
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
Related subjects:
© 2021 Anna Jana Saulīte, Anna Popova, Renārs Erts, Kārlis Rācenis, Linda Kučāne, Aivars Pētersons, Arvydas Laurinavičius, Harijs Čerņevskis, Viktorija Kuzema, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.